Clinical Trials Browser

Phase 1 × INDUSTRY × bermekimab × Clear all

NCT01260545 2021-02-16

Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms